Volume 156, Issue 5, Pages (April 2019)

Slides:

Advertisements

Similar presentations

Esophageal Adenocarcinoma

Advertisements

Gastrin in Gastrointestinal Diseases

Complications of Proton Pump Inhibitor Therapy

Volume 152, Issue 4, Pages e1 (March 2017)

Barrett's Esophagus: Evolutionary Insights From Genomics

Volume 152, Issue 4, Pages (March 2017)

Pancreatic Mass in a Patient With an Increased Serum Level of IgG4

Christoph Lübbert, Babett Holler Gastroenterology

Community Colonoscopy: A Gordian Knot?

Evaluation and Management of End-Stage Liver Disease in Children

Michael F. Vaezi, David Katzka, Frank Zerbib

Volume 154, Issue 5, Pages e3 (April 2018)

Proton Pump Inhibitors for Gastroduodenal Damage Related to Nonsteroidal Anti- inflammatory Drugs or Aspirin: Twelve Important Questions for Clinical Practice

Nadir Arber, Bernard Levin Gastroenterology

Coordinating Care in Patients With Cirrhosis

Waist-to-Hip Ratio, but Not Body Mass Index, Is Associated With an Increased Risk of Barrett's Esophagus in White Men Jennifer R. Kramer, Lori A. Fischbach,

Persistent Reflux Symptoms in the Proton Pump Inhibitor Era: The Changing Face of Gastroesophageal Reflux Disease Evan S. Dellon, Nicholas J. Shaheen

Body Composition and Barrett’s Esophagus

Ira J. Fox, Stephen C. Strom Gastroenterology

Rana Sabbagh, Edi Levi, Fadi Antaki Gastroenterology

Volume 154, Issue 8, Pages e5 (June 2018)

American Gastroenterological Association Institute Technical Review on the Management of Gastroesophageal Reflux Disease Peter J. Kahrilas, Nicholas.

A Model to Determine Absolute Risk for Esophageal Adenocarcinoma

Intragastric pH With Oral vs Intravenous Bolus Plus Infusion Proton-Pump Inhibitor Therapy in Patients With Bleeding Ulcers Loren Laine, Abbid Shah,

Success as a PhD in Gastroenterology

Clinical Challenges and Images in GI

Persistent Reflux Symptoms in the Proton Pump Inhibitor Era: The Changing Face of Gastroesophageal Reflux Disease Evan S. Dellon, Nicholas J. Shaheen

Serhat Bor, Gul Kitapcioglu, Peter Dettmar, Tim Baxter

Volume 153, Issue 3, Pages e16-e17 (September 2017)

Management of Patients With Functional Heartburn

A Historical Perspective on Clinical Advances in Pancreatic Diseases

Volume 150, Issue 4, Pages (April 2016)

Adverse Events After Implantation of a Magnetic Sphincter Augmentation Device for Gastroesophageal Reflux Klaus Bielefeldt, MD, PhD Clinical Gastroenterology.

Clinical Challenges and Images in GI

Sibu Varghese, Pierre Lao–Sirieix, Rebecca C. Fitzgerald

Volume 136, Issue 4, Pages e2 (April 2009)

Endoscopic Therapy for Barrett's Esophagus

David J. Hass, Colleen M. Brensinger, James D. Lewis, Gary R

Patrick Hoversten, Fouad Otaki, David A. Katzka

Many Patients Continue Using Proton Pump Inhibitors After Negative Results From Tests for Reflux Disease Andrew J. Gawron, Jami Rothe, Angela J. Fought,

Volume 155, Issue 6, Pages (December 2018)

Volume 154, Issue 5, Pages (April 2018)

Risk of Upper Gastrointestinal Cancers in Patients With Gastroesophageal Reflux Disease After a Negative Screening Endoscopy Mohammad H. Shakhatreh,

An Unlikely Lesion to Be Identified in the Cervical Esophagus

Peter Bytzer Clinical Gastroenterology and Hepatology

Volume 133, Issue 2, Pages (August 2007)

Ikuo Hirano, MD Clinical Gastroenterology and Hepatology

Ashwin N. Ananthakrishnan, David Lieberman Gastroenterology

Volume 154, Issue 4, Pages (March 2018)

Volume 148, Issue 3, Pages (March 2015)

Systematic Review: Patterns of Proton Pump Inhibitor Use and Adherence in Gastroesophageal Reflux Disease A. Pali S. Hungin, Catherine Hill, Michael.

Volume 149, Issue 6, Pages (November 2015)

Kavita Patel, Elise Presser, Meaghan George, Mark McClellan

Volume 150, Issue 7, Pages (June 2016)

The Rise and Fall (and Rise?) of Endoscopic Anti-Reflux Procedures

Manuel Romero-Gómez, Javier Ampuero Gastroenterology

The Utility of Intraluminal Impedance in Patients With Gastroesophageal Reflux Disease–Like Symptoms But Normal Endoscopy and 24-Hour pH Testing Michael.

The Dawning of a New Editorial Board for Gastroenterology

Volume 151, Issue 4, Pages (October 2016)

Baby-Epsilon Steps Toward the Triple Aim

Risks Associated With Anesthesia Services During Colonoscopy

Michelle Maria Pietzak Gastroenterology

Volume 155, Issue 6, Pages (December 2018)

Issue Highlights Clinical Gastroenterology and Hepatology

Lauren B. Gerson, Peter J. Kahrilas, Ronnie Fass

Volume 138, Issue 6, Pages (May 2010)

End-Stage Liver Disease in 2008: Finally a Glass Half Full

Electronic Clinical Challenges and Images in GI

Statin Use Is Associated With a Decreased Risk of Barrett’s Esophagus

Volume 156, Issue 4, Pages (March 2019)

Presentation transcript:

Volume 156, Issue 5, Pages 1228-1231 (April 2019) Will a Proton Pump Inhibitor and an Aspirin Keep the Doctor Away for Patients With Barrett’s Esophagus? Rebecca C. Fitzgerald Gastroenterology Volume 156, Issue 5, Pages 1228-1231 (April 2019) DOI: 10.1053/j.gastro.2019.03.001 Copyright © 2019 AGA Institute Terms and Conditions

Figure 1 A hypothetical approach to screening, diagnosis, and intervention for the management of Barrett’s esophagus (BE). Primary care screening would identify patients for endoscopy referral. A BE diagnosis, along with molecular profiling and clinical factors, would allow stratification into low-risk or high-risk groups, which would have distinct intervention approaches. BMI, body mass index; GERD, gastroesophageal reflux disease; PPI, proton pump inhibitor. Gastroenterology 2019 156, 1228-1231DOI: (10.1053/j.gastro.2019.03.001) Copyright © 2019 AGA Institute Terms and Conditions